Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

TELA TELA Bio, Inc. Common Stock
$0.76 -7.12% -0.06
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TELA stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

TELA Bio, Inc. Common Stock (TELA)

Loading

Key Stats

Market cap. 34.4M
Enterprise value 70.7M
Trailing PE -0.93506021671985
Forward PE -1.7085418
PEG Ratio 0.10285662383918
Enterprise to EBITDA -2.16
Enterprise to revenue 0.904
Price to book MRQ -2.8084762158501
Price to sales TTM 0.47403193

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 78.2M
EBITDA -32725000
Diluted EPS TTM -0.74
Total Cash (MRQ) 22.7M
Current ratio (MRQ) 0.612
Operating Cash Flow (TTM) -34113000

TELA trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent TELA News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.